Competitive Technologies' Calmare(R) Pain Therapy Treatment to Treat Patients at...

Competitive Technologies' Calmare(R) Pain Therapy Treatment to Treat Patients at
Walter Reed Army Medical Center

FAIRFIELD, Conn., June 4, 2010 (GLOBE NEWSWIRE) -- Competitive Technologies,
Inc. (NYSE Amex:CTT) announced today that the Walter Reed Army Medical Center in
Washington, D.C., has joined the growing list of organizations that will treat
pain patients with CTT's Calmare(R) Pain Therapy Treatment, as authorized by the
Surgeon General of the U.S. Army and Commanding General of the U.S. Army Medical
Command. The Calmare Pain Therapy Treatment will be used to treat wounded
warriors and other military personnel who are suffering from neuropathic pain.

"We are pleased to have this opportunity to make a difference in the lives of
those who have given so much in defense of our great nation," said John B. Nano,
CTT's Chairman, President and CEO. "With over 60% of our returning veterans
suffering from significant pain, as reported at last month's American Pain
Society annual meeting, we are glad to be able to offer these wounded warriors
and their physicians a non-invasive pain relief option without the harmful,
adverse side effects associated with powerful opioids, such as morphine. Calmare
Pain Therapy successfully treats chronic neuropathic pain resulting from phantom
limb syndrome, shingles, failed back surgery, sciatica, spinal stenosis and
other maladies."

"As a veteran, I am thrilled to see Walter Reed Army Medical Center added to the
growing number of respected medical institutions treating patients with CTT's
Calmare Pain Therapy," said Jean Wilczynski of IR Services, LLC. "I believe it
is of utmost importance that our wounded warriors and service members suffering
from serious injuries and severe, debilitating pain be provided with the best
possible treatment options, especially those that can help them avoid the
harmful side effects of powerful opioids and other medications."

Calmare is currently being used at the Virginia Commonwealth University Massey
Cancer Center, the Paul Carbone Cancer Center at the University of Wisconsin,
Madison, and the University of Miami Pain Management Center. Calmare is also
being used to treat international patients in Italy, India, Greece, Bangladesh,
and U.S. patients at clinics in Massachusetts, New York, Virginia, Florida,
Connecticut and Rhode Island.

The non-invasive Calmare pain therapy device uses the biophysical "Scrambler
Therapy" technology, which was developed in Italy by CTT's client, Professor
Giuseppe Marineo. CTT's partner, GEOMC Co. Ltd. of Seoul, Korea is currently
manufacturing the Calmare device, which has U.S. FDA clearance and European
Union CE Mark clearance for sales. For more information on the device, visit
www.calmarett.com.

About Walter Reed Army Medical Center

The Walter Reed Army Medical Center is the hub of the Walter Reed Health Care
System and provides comprehensive health care to more than 150,000 Service
Members, retirees and their families. Walter Reed Army Medical Center is the
largest Department of Defense military hospital serving the military community
from the Washington area and around the world. For more information, visit
www.wramc.army.mil.

About Competitive Technologies, Inc.

Competitive Technologies, established in 1968, provides distribution, patent and
technology transfer, sales and licensing services focused on the needs of its
customers and matching those requirements with commercially viable product or
technology solutions. CTT is a global leader in identifying, developing and
commercializing innovative products and technologies in life, electronic, nano,
and physical sciences developed by universities, companies and inventors. CTT
maximizes the value of intellectual assets for the benefit of its customers,
clients and shareholders. Visit CTT's website: www.competitivetech.net

Statements made about our future expectations are forward-looking statements and
subject to risks and uncertainties as described in our most recent Annual Report
on Form 10-K for the year ended July 31, 2008, filed with the SEC on October 28,
2008, and other filings with the SEC, and are subject to change at any time. Our
actual results could differ materially from these forward-looking statements. We
undertake no obligation to update publicly any forward-looking statement.

CONTACT: IR Services, LLC
Johnnie D. Johnson
860 434 2465
jdjohnson@corpirservices.com